title: Characterization of kinase inhibitors using reverse phase protein arrays.
abstract: Using the reverse protein array platform in combination with planar waveguide technology, which allows detection of proteins in spotted cell lysates with high sensitivity in a 96-well microtiter-plate format for growing, treating, and lysing cells was shown to be suitable for this approach and indicates the usefulness of the technology as a screening tool for characterization of large numbers of kinase inhibitors. In this study, we have used reverse protein arrays to profile kinase inhibitors in various cellular pathways in order to unravel their MoA. Multiplexing and simultaneous analysis of several phospho-proteins within the same lysate allows (1) the estimation of inhibitor concentrations needed to shut down an entire pathway, (2) the estimation of inhibitor selectivity, and (3) the comparison of inhibitors of different kinases within one assay. For example, parallel analysis of p-InsR, p-PKB, p-GSK-3, p-MEK, p-ERK, and p-S6rp in insulin treated A14 cells allows profiling for inhibitors of the InsR, PI3K, PKB, mTor, RAF, and MEK. Selective kinase inhibitors revealed different specific inhibitory pattern of the analyzed phospho-read outs. Altogether, multiplexed analysis of reverse (phase) protein arrays is a powerful tool to characterize kinase inhibitors in a semi-automated low to medium throughput assay format.
authors: Center for Proteomic Chemistry, Novartis Pharma AG, Basel, Switzerland.
authors: Georg
authors: G
authors: Martiny-Baron
authors: Dorothea
authors: D
authors: Haasen
authors: Daniel
authors: D
authors: D'Dorazio
authors: Johannes
authors: J
authors: Voshol
authors: Doriano
authors: D
authors: Fabbro
mesh_terms: D000818:Animals; D000906:Antibodies; D000918:Antibody Specificity; D018929:Cell Culture Techniques; D045744:Cell Line, Tumor; D006801:Humans; D051379:Mice; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D040081:Protein Array Analysis / Q000295:instrumentation / Q000379:methods*; D047428:Protein Kinase Inhibitors / Q000302:isolation & purification*; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction / Q000235:genetics*
chemical_list: D000906:Antibodies; D010750:Phosphoproteins; D047428:Protein Kinase Inhibitors